Parker M
Eur J Clin Pharmacol. 1975 Feb 28;8(2):131-4. doi: 10.1007/BF00561562.
Details are given of 17 patients who developed parotid pain during treatment with guanacline and which persisted after cessation of guanacline for upto five and a half years. These patients are compared with 17 patients who received similar treatment with guanacline and who did not develop parotid pain. There was no significant difference between patients who experienced parotid pain and those who did not with respect to sex, age, clinical diagnosis, blood urea, previous hypotensive therapy or other drugs given concurrently with guanacline. There was a slightly greater association of parotid pain with other side effects and with a larger daily dose of guanacline. It is suggested that persistent parotid pain after guanacline therapy is due to prolonged or permanent selective sympathetic nerve damage in the region of the cervical sympathetic nerve supply to the salivary glands.
详细介绍了17例在胍那克林治疗期间出现腮腺疼痛且在停用胍那克林后持续长达五年半的患者。将这些患者与17例接受类似胍那克林治疗但未出现腮腺疼痛的患者进行了比较。在经历腮腺疼痛的患者与未经历腮腺疼痛的患者之间,在性别、年龄、临床诊断、血尿素、既往降压治疗或与胍那克林同时使用的其他药物方面没有显著差异。腮腺疼痛与其他副作用以及较大的胍那克林日剂量之间的关联略强。提示胍那克林治疗后持续的腮腺疼痛是由于颈部交感神经对唾液腺的供应区域出现了长期或永久性的选择性交感神经损伤。